» Articles » PMID: 17223707

Nonpolar Substitution at the C-terminus of the Prion Protein, a Mimic of the Glycosylphosphatidylinositol Anchor, Partially Impairs Amyloid Fibril Formation

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2007 Jan 17
PMID 17223707
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

In contrast to most amyloidogenic proteins or peptides that do not contain any significant posttranslational modifications, the prion protein (PrP) is modified with either one or two polysaccharides and a GPI anchor which attaches PrP to the plasma membrane. Like other amyloidogenic proteins, however, PrP adopts a fibrillar shape when converted to a disease-specific conformation. Therefore, PrP polymerization offers a unique opportunity to examine the effects of biologically relevant nonpeptidic modifications on conversion to the amyloid conformation. To test the extent to which a long hydrophobic chain at the C-terminus affects the intrinsic amyloidogenic propensity of PrP, we modified recombinant PrP with an N-myristoylamidomaleimidyl group, which can serve as a membrane anchor. We show that while this modification increases the affinity of PrP for the cell membrane, it does not alter the structure of the protein. Myristoylation of PrP affected amyloid formation in two ways: (i) it substantially decreased the extent of fibrillation, presumably due to off-pathway aggregation, and (ii) it prohibited assembly of filaments into higher order fibrils by preventing their lateral association. The negative effect on lateral association was abolished if the myristoylated moiety at the C-terminus was replaced by a polar group of similar size or by a hydrophobic group of smaller size. When preformed PrP fibrils were provided as seeds, myristoylated PrP supported fibril elongation and formation of higher order fibrils composed of several filaments. Our studies illustrate that, despite a bulky hydrophobic moiety at C-terminus, myristoylated PrP can still incorporate into fibrillar structure and that the C-terminal hydrophobic substitution does not affect the size of the proteinase K resistant core but controls the mode of lateral assembly of filaments into higher order fibrils.

Citing Articles

From Posttranslational Modifications to Disease Phenotype: A Substrate Selection Hypothesis in Neurodegenerative Diseases.

Baskakov I Int J Mol Sci. 2021; 22(2).

PMID: 33477465 PMC: 7830165. DOI: 10.3390/ijms22020901.


Prion protein-Semisynthetic prion protein (PrP) variants with posttranslational modifications.

Hackl S, Becker C J Pept Sci. 2019; 25(10):e3216.

PMID: 31713950 PMC: 6899880. DOI: 10.1002/psc.3216.


Preserving prion strain identity upon replication of prions in vitro using recombinant prion protein.

Makarava N, Savtchenko R, Lasch P, Beekes M, Baskakov I Acta Neuropathol Commun. 2018; 6(1):92.

PMID: 30208966 PMC: 6134792. DOI: 10.1186/s40478-018-0597-y.


Semisynthetic prion protein (PrP) variants carrying glycan mimics at position 181 and 197 do not form fibrils.

Araman C, Thompson R, Wang S, Hackl S, Payne R, Becker C Chem Sci. 2017; 8(9):6626-6632.

PMID: 28989689 PMC: 5625290. DOI: 10.1039/c7sc02719b.


Sialylation of Glycosylphosphatidylinositol (GPI) Anchors of Mammalian Prions Is Regulated in a Host-, Tissue-, and Cell-specific Manner.

Katorcha E, Srivastava S, Klimova N, Baskakov I J Biol Chem. 2016; 291(33):17009-19.

PMID: 27317661 PMC: 5016106. DOI: 10.1074/jbc.M116.732040.


References
1.
Liberski P, Brown P, Xiao S, Gajdusek D . The ultrastructural diversity of scrapie-associated fibrils isolated from experimental scrapie and Creutzfeldt-Jakob disease. J Comp Pathol. 1991; 105(4):377-86. DOI: 10.1016/s0021-9975(08)80107-7. View

2.
Leffers K, Wille H, Stohr J, Junger E, Prusiner S, Riesner D . Assembly of natural and recombinant prion protein into fibrils. Biol Chem. 2005; 386(6):569-80. DOI: 10.1515/BC.2005.067. View

3.
Borchelt D, Rogers M, Stahl N, Telling G, Prusiner S . Release of the cellular prion protein from cultured cells after loss of its glycoinositol phospholipid anchor. Glycobiology. 1993; 3(4):319-29. DOI: 10.1093/glycob/3.4.319. View

4.
Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, Prusiner S . Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol. 1995; 129(1):121-32. PMC: 2120366. DOI: 10.1083/jcb.129.1.121. View

5.
Vey M, Pilkuhn S, Wille H, Nixon R, DeArmond S, Smart E . Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci U S A. 1996; 93(25):14945-9. PMC: 26242. DOI: 10.1073/pnas.93.25.14945. View